BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31625976)

  • 1. Regulator of G-protein signaling 5 protein protects against anxiety- and depression-like behavior.
    DʼSouza MS; Guisinger TC; Norman H; Seeley SL; Chrissobolis S
    Behav Pharmacol; 2019 Dec; 30(8):712-721. PubMed ID: 31625976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G-Protein Signaling 5 Protein Deficiency Differentially Influences Blood Pressure, Vascular and Behavioral Effects in Aged Male Mice.
    D'Souza MS; Luu AN; Guisinger TC; Seeley SL; Waldschmidt RA; Chrissobolis S
    J Cardiovasc Pharmacol; 2022 Aug; 80(2):305-313. PubMed ID: 35384894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.
    Hong K; Li M; Nourian Z; Meininger GA; Hill MA
    Hypertension; 2017 Dec; 70(6):1264-1272. PubMed ID: 29061726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.
    Holobotovskyy V; Manzur M; Tare M; Burchell J; Bolitho E; Viola H; Hool LC; Arnolda LF; McKitrick DJ; Ganss R
    Circ Res; 2013 Mar; 112(5):781-91. PubMed ID: 23303165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2: roles of its N-terminal domain.
    Matsuzaki N; Nishiyama M; Song D; Moroi K; Kimura S
    Cell Signal; 2011 Jun; 23(6):1041-9. PubMed ID: 21291998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.
    Romero M; Jiménez R; Toral M; León-Gómez E; Gómez-Gúzman M; Sánchez M; Zarzuelo MJ; Rodríguez-Gómez I; Rath G; Tamargo J; Pérez-Vizcaíno F; Dessy C; Duarte J
    J Pharmacol Exp Ther; 2016 Jul; 358(1):151-63. PubMed ID: 27189971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of G-Protein Signaling 5 Maintains Brain Endothelial Cell Function in Focal Cerebral Ischemia.
    Sladojevic N; Yu B; Liao JK
    J Am Heart Assoc; 2020 Sep; 9(18):e017533. PubMed ID: 32875943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia.
    Holobotovskyy V; Chong YS; Burchell J; He B; Phillips M; Leader L; Murphy TV; Sandow SL; McKitrick DJ; Charles AK; Tare M; Arnolda LF; Ganss R
    Sci Transl Med; 2015 Jun; 7(290):290ra88. PubMed ID: 26041705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition of angiotensin AT1 receptor signaling by RGS8: importance of the C-terminal third exon part of its RGS domain.
    Song D; Nishiyama M; Kimura S
    J Recept Signal Transduct Res; 2016 Oct; 36(5):478-87. PubMed ID: 26754208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension-evoked RhoA activity in vascular smooth muscle cells requires RGS5.
    Arnold C; Demirel E; Feldner A; Genové G; Zhang H; Sticht C; Wieland T; Hecker M; Heximer S; Korff T
    FASEB J; 2018 Apr; 32(4):2021-2035. PubMed ID: 29208700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase.
    Zimnol A; Amann K; Mandel P; Hartmann C; Schupp N
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1264-F1273. PubMed ID: 28877878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Rgs5 prolongs cardiac repolarization and predisposes to ventricular tachyarrhythmia in mice.
    Qin M; Huang H; Wang T; Hu H; Liu Y; Cao H; Li H; Huang C
    J Mol Cell Cardiol; 2012 Dec; 53(6):880-90. PubMed ID: 23079193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation.
    Cho H; Kozasa T; Bondjers C; Betsholtz C; Kehrl JH
    FASEB J; 2003 Mar; 17(3):440-2. PubMed ID: 12514120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulator of G-protein signaling 5 protects cardiomyocytes against apoptosis during in vitro cardiac ischemia-reperfusion in mice by inhibiting both JNK1/2 and P38 signaling pathways.
    Wang Z; Huang H; He W; Kong B; Hu H; Fan Y; Liao J; Wang L; Mei Y; Liu W; Xiong X; Peng J; Xiao Y; Huang D; Quan D; Li Q; Xiong L; Zhong P; Wang G
    Biochem Biophys Res Commun; 2016 Apr; 473(2):551-7. PubMed ID: 27021681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of RGS5 in regulation of G protein-coupled receptor signaling.
    Zhou J; Moroi K; Nishiyama M; Usui H; Seki N; Ishida J; Fukamizu A; Kimura S
    Life Sci; 2001 Feb; 68(13):1457-69. PubMed ID: 11253162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.
    Wang X; Adams LD; Pabón LM; Mahoney WM; Beaudry D; Gunaje J; Geary RL; Deblois D; Schwartz SM
    J Mol Cell Cardiol; 2008 Mar; 44(3):539-50. PubMed ID: 18207159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus.
    Cho H; Park C; Hwang IY; Han SB; Schimel D; Despres D; Kehrl JH
    Mol Cell Biol; 2008 Apr; 28(8):2590-7. PubMed ID: 18268011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-Methyltransferase Deficiency Leads to Hypersensitivity of the Pressor Response Against Angiotensin II.
    Ueki N; Kanasaki K; Kanasaki M; Takeda S; Koya D
    Hypertension; 2017 Jun; 69(6):1156-1164. PubMed ID: 28461606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.